Literature DB >> 23752114

Vemurafenib-induced cardiac tamponade: a rare but potentially life-threatening complication.

Kathleen M Mahoney1, Allison Ackerman, Daniel C Cho, David F McDermott, Toni Peters, Michael B Atkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23752114     DOI： 10.1200/JCO.2012.47.0104

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Cardiotoxicity of Systemic Melanoma Treatments.

Authors:  Neha Mukunda; Srilakshmi Vallabhaneni; Benedicte Lefebvre; Michael G Fradley
Journal:  Curr Treat Options Oncol       Date:  2022-02-22

Review 2.  Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma.

Authors:  Sarah J Welsh; Pippa G Corrie
Journal:  Ther Adv Med Oncol       Date:  2015-03       Impact factor: 8.168

Review 3.  What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment.

Authors:  Enrico Bronte; Giuseppe Bronte; Giuseppina Novo; Fabrizio Bronte; Maria Grazia Bavetta; Giuseppe Lo Re; Giuseppe Brancatelli; Viviana Bazan; Clara Natoli; Salvatore Novo; Antonio Russo
Journal:  Oncotarget       Date:  2015-11-03

4.  Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma: Case report.

Authors:  Vinita Ruth Sundaram; Tahir Abbas
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.